Savara's Series C Round

Savara raised a round of funding on December 17, 2015.

Savara (NASDAQ: SVRA) is a clinical-stage specialty pharmaceutical company focused on the development and commercialization of novel therapies for the treatment of serious or life-threatening rare res…

Articles about Savara's Series C Round: